Human Umbilical Cord Blood Mononuclear Cells in a Double-Hit Model of Bronchopulmonary Dysplasia in Neonatal Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Monz, Dominik ^a   Tutdibi, Erol ^a   Mildau, Céline ^a   Shen, Jie ^a,b   Kasoha, Mariz ^a   Laschke, Matthias W ^a   Roolfs, Torge ^c   Schmiedl, Andreas ^c   Tschernig, Thomas ^a   Bieback, Karen ^d   Gortner, Ludwig ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; OXYGEN; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOL BINDING PROTEIN; SOMATOMEDIN C; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE MODEL; ELECTRON MICROSCOPY; FETUS LUNG MATURATION; HUMAN; HUMAN CELL; HYPEROXIA; HYPOXIA; LAMELLAR BODY; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG STRUCTURE; MONONUCLEAR CELL; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; PHYSICAL DEVELOPMENT; PNEUMONIA; PROTEIN EXPRESSION; UMBILICAL CORD; UMBILICAL CORD MONONUCLEAR CELL; UMBILICAL CORD MONONUCLEAR CELL TRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINES; DISEASE MODELS, ANIMAL; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPEROXIA; LEUKOCYTES, MONONUCLEAR; LUNG; MICE; PNEUMOCYTES;

EID: 84884394476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074740     Document Type: Article

References (48)

1. Gortner L, Misselwitz B, Milligan D, Zeitlin J, Kollée L, et al. (2011) Rates of bronchopulmonary dysplasia in very preterm neonates in europe: Results from the MOSAIC cohort. Neonatology 99: 112-117. doi:10.1159/000313024. PubMed: 20733331.
2. Jobe AH, (2011) The new bronchopulmonary dysplasia. Curr Opin Pediatr 23: 167-172. doi:10.1097/MOP.0b013e3283423e6b. PubMed: 21169836.
3. Ahlfeld SK, Conway SJ, (2012) Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 94: 3-15. doi:10.1002/bdra.22869. PubMed: 22125178.
4. O'Reilly M, Sozo F, Harding R, (2013) The impact of preterm birth and bronchopulmonary dysplasia on the developing lung: Long-term consequences for respiratory health. Clin Exp Pharmacol Physiol.
5. Zeitlin J, El Ayoubi M, Jarreau PH, Draper ES, Blondel B, et al. (2010) Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 157: 733-9.e1. PubMed: 20955846.
6. Baker CD, Abman SH, (2013) Umbilical cord stem cell therapy for bronchopulmonary dysplasia: Ready for prime time? Thorax 68: 402-4. PubMed: 23321604.
7. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, et al. (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350: 1304-1313. doi:10.1056/NEJMoa032089. PubMed: 15044641.
8. Bassler D, Stoll BJ, Schmidt B, Asztalos EV, Roberts RS, et al. (2009) Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: Added role of neonatal infection. Pediatrics 123: 313-318. doi:10.1542/peds.2008-0377. PubMed: 19117897.
9. Van Marter LJ, Kuban KC, Allred E, Bose C, Dammann O, et al. (2011) Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed 96: F20-F29 doi:10.1136/adc.2010.183012. PubMed: 20736416.
10. Sng J, Lufkin T, (2012) Emerging stem cell therapies: Treatment, safety, and biology. Stem Cells Int,(2012): pp. 521343. PubMed: 22919402.
11. van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, et al. (2009) Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180: 1131-1142. doi:10.1164/rccm.200902-0179OC. PubMed: 19713449.
12. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, et al. (2009) Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130. doi:10.1164/rccm.200902-0242OC. PubMed: 19713447.
13. Zhang X, Wang H, Shi Y, Peng W, Zhang S, et al. (2012) Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 36: 589-594. doi:10.1042/CBI20110447. PubMed: 22339670.
14. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, et al. (2009) Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 18: 869-886. doi:10.3727/096368909X471189. PubMed: 19500472.
15. Kögler G, Critser P, Trapp T, Yoder M, (2009) Future of cord blood for non-oncology uses. Bone Marrow Transplant 44: 683-697. doi:10.1038/bmt.2009.287. PubMed: 19802027.
16. Chang YS, Choi SJ, Ahn SY, Sung DK, Sung SI, et al. (2013) Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLOS ONE 8: e52419. doi:10.1371/journal.pone.0052419. PubMed: 23349686.
17. Mayani H, Alvarado-Moreno JA, Flores-Guzmán P, (2003) Biology of human hematopoietic stem and progenitor cells present in circulation. Arch Med Res 34: 476-488. doi:10.1016/j.arcmed.2003.08.004. PubMed: 14734087.
18. Gortner L, Hilgendorff A, Bähner T, Ebsen M, Reiss I, et al. (2005) Hypoxia-induced intrauterine growth retardation: Effects on pulmonary development and surfactant protein transcription. Biol Neonate 88: 129-135. doi:10.1159/000085895. PubMed: 15908743.
19. Gortner L, Monz D, Mildau C, Shen J, Kasoha M, et al. (2013) Bronchopulmonary dysplasia in a double-hit mouse model induced by intrauterine hypoxia and postnatal hyperoxia: Closer to clinical features? Ann Anat 195: 351-358. doi:10.1016/j.aanat.2013.02.010. PubMed: 23684450.
20. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG, (2010) Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLOS Biol 8: e1000412. PubMed: 22424462223904252135061720613859.
21. Heimfeld S, (2003) Bone marrow transplantation: How important is CD34 cell dose in HLA-identical stem cell transplantation? Leukemia 17: 856-858. doi:10.1038/sj.leu.2402893. PubMed: 12750697.
22. Pereira-Cunha FG, Duarte AS, Costa FF, Saad ST, Lorand-Metze I, et al. (2013) Viability of umbilical cord blood mononuclear cell subsets until 96 hours after collection. Transfusion, 53: 2034-42. PubMed: 23320473.
23. Hsia CC, Hyde DM, Ochs M, Weibel ER, ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure (2010) An official research policy statement of the american thoracic Society/European respiratory society: Standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 181: 394-418. doi:10.1164/rccm.200809-1522ST. PubMed: 20130146.
24. Fehrenbach H, Ochs M, (1998) Studying lung ultrastructure. In: Uhlig S., [!(surname)!], eds. Methods in pulmonary research. Basel: Birkhäuser Verlag. pp. pp. 429-454.
25. Tutdibi E, Hunecke A, Lindner U, Monz D, Gortner L, (2012) Levels of cytokines in umbilical cord blood in relation to spontaneous term labor. J Perinat Med 40: 527-532. PubMed: 23104795.
26. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622. doi:10.1373/clinchem.2008.112797. PubMed: 19246619.
27. Ramakers C, Ruijter JM, Deprez RH, Moorman AF, (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66. doi:10.1016/S0304-3940(02)01423-4. PubMed: 12618301.
28. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36. doi:10.1093/nar/30.9.e36. PubMed: 11972351.
29. Santibanez JF, Quintanilla M, Bernabeu C, (2011) TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 121: 233-251. doi:10.1042/CS20110086.
30. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, et al. (2003) Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 163: 2575-2584. doi:10.1016/S0002-9440(10)63612-7. PubMed: 14633629.
31. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, et al. (2004) Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: A new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31: 650-656. doi:10.1165/rcmb.2004-0092OC. PubMed: 15333328.
32. Warburton D, (2012) Developmental responses to lung injury: Repair or fibrosis. Fibrogenesis Tissue Repair 5 (Suppl 1):: S2. doi:10.1186/1755-1536-5-2. PubMed: 23259863.
33. Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, et al. (2007) Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292: L537-L549. PubMed: 17071723.
34. Laplante M, Sabatini DM, (2012) mTOR signaling in growth control and disease. Cell 149: 274-293. doi:10.1016/j.cell.2012.03.017. PubMed: 22500797.
35. Waickman AT, Powell JD, (2012) mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev 249: 43-58. doi:10.1111/j.1600-065X.2012.01152.x. PubMed: 22889214.
36. Hwang SK, Kim HH, (2011) The functions of mTOR in ischemic diseases. BMB Rep 44: 506-511. doi:10.5483/BMBRep.2011.44.8.506. PubMed: 21871173.
37. Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, et al. (2008) The mTOR pathway and its role in human genetic diseases. Mutat Res 659: 284-292. doi:10.1016/j.mrrev.2008.06.001. PubMed: 18598780.
38. Goncharova EA, (2013) mTOR and vascular remodeling in lung diseases: Current challenges and therapeutic prospects. FASEB J, 27: 1796-807. PubMed: 23355268.
39. Fielhaber JA, Carroll SF, Dydensborg AB, Shourian M, Triantafillopoulos A, et al. (2012) Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis. J Immunol 188: 4535-4542. doi:10.4049/jimmunol.1003655. PubMed: 22450807.
40. Bry K, Hogmalm A, Bäckström E, (2010) Mechanisms of inflammatory lung injury in the neonate: Lessons from a transgenic mouse model of bronchopulmonary dysplasia. Semin Perinatol 34: 211-221. doi:10.1053/j.semperi.2010.02.006. PubMed: 20494738.
41. Deakins KM, (2009) Bronchopulmonary dysplasia. Respir Care 54: 1252-1262. PubMed: 19712501.
42. Cerny L, Torday JS, Rehan VK, (2008) Prevention and treatment of bronchopulmonary dysplasia: Contemporary status and future outlook. Lung 186: 75-89. doi:10.1007/s00408-007-9069-z. PubMed: 18228098.
43. Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, et al. (2012) Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax, 68: 475-84. PubMed: 23212278.
44. Maritz GS, Cock ML, Louey S, Joyce BJ, Albuquerque CA, et al. (2001) Effects of fetal growth restriction on lung development before and after birth: A morphometric analysis. Pediatr Pulmonol 32: 201-210. doi:10.1002/ppul.1109. PubMed: 11536449.
45. Wright RJ, (2010) Perinatal stress and early life programming of lung structure and function. Biol Psychol 84: 46-56. doi:10.1016/j.biopsycho.2010.01.007. PubMed: 20080145.
46. Hochberg Z, (2011) Developmental plasticity in child growth and maturation. Front Endocrinol (Lausanne)2: 41.
47. Gluckman PD, Hanson MA, Cooper C, Thornburg KL, (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359: 61-73. doi:10.1056/NEJMra0708473. PubMed: 18596274.
48. Gluckman PD, Hanson MA, Beedle AS, (2007) Early life events and their consequences for later disease: A life history and evolutionary perspective. Am J Hum Biol 19: 1-19. doi:10.1002/ajhb.20590. PubMed: 17160980.